Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-23

Clinical Trial Update: CHF6467 SAD and MAD in Patients With Diabetic Foot Ulcer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trials update for CHF6467 in diabetic neuropathic foot ulcers across Phase 1 and Phase 2 have completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CHF6467

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Diabetic Neuropathic Foot Ulcers | Phase 1, Phase 2 | Status: COMPLETED